EVP, Chief Legal Officer of Alnylam Pharmaceuticals Inc (30-Year Financial, Insider Trades) Laurie Keating (insider trades) sold 10,000 shares of ALNY on 04/20/2020 at an average price of $139 a share. The total sale was $1.4 million.
Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes. Alnylam Pharmaceuticals Inc has a market cap of $15.98 billion; its shares were traded at around $140.11 with and P/S ratio of 69.58. GuruFocus has detected 2 severe warning signs with Alnylam Pharmaceuticals Inc. .
Directors and Officers Recent Trades:
- EVP, Chief Legal Officer Laurie Keating sold 10,000 shares of ALNY stock on 04/20/2020 at the average price of $139. The price of the stock has increased by 0.8% since.
- President, R&D Akshay Vaishnaw sold 21,971 shares of ALNY stock on 04/20/2020 at the average price of $140. The price of the stock has increased by 0.08% since.
For the complete insider trading history of ALNY, click here
.